Free Trial

Immunic (IMUX) Earnings Date, Estimates & Call Transcripts

Immunic logo
$0.95 0.00 (-0.31%)
Closing price 04:00 PM Eastern
Extended Trading
$0.96 +0.01 (+0.53%)
As of 07:54 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Immunic Latest Earnings Summary

Upcoming Q4
Earnings Date
Feb. 20Before Market OpensEstimated
Actual EPS
(Nov. 7)
-$0.24 Missed By -$0.02
Consensus EPS
(Nov. 7)
-$0.22

Immunic announced Q3 2024 earnings on November 7, 2024, reporting an EPS of -$0.24, which missed analysts' consensus estimates of -$0.22 by $0.02. With a trailing EPS of -$1.23, Immunic's earnings are expected to grow next year, from ($0.94) to ($0.82) per share.

IMUX Upcoming Earnings

Immunic's next earnings date is estimated for Thursday, February 20, 2025, based off prior year's reporting schedules.

Get Immunic Earnings Alerts

Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Immunic and other key companies, straight to your inbox.

Sign Up
Skip Charts & View Estimated and Actual Earnings Data

IMUX Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

IMUX Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Immunic Analyst EPS Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20253-$0.29-$0.20-$0.25
Q2 20253-$0.29-$0.13-$0.22
Q3 20253-$0.30-$0.13-$0.23
Q4 20253-$0.35-$0.12-$0.24
FY 202512($1.23)($0.58)($0.95)

Immunic Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails
2/20/2025
(Estimated)
-------
11/7/2024Q3 2024-$0.22-$0.24 -$0.02-$0.24--
8/8/2024Q2 2024-$0.23-$0.21+$0.02-$0.21--
5/8/2024Q1 2024-$0.27-$0.25+$0.02-$0.20--
2/22/2024Q4 2023-$0.51-$0.48+$0.03-$0.48--
11/14/2023Q3 2023-$0.55-$0.51+$0.04-$0.51--
8/3/2023Q2 2023-$0.52-$0.54 -$0.02-$0.54--
5/11/2023Q1 2023-$0.54-$0.58 -$0.04-$0.58--
2/23/2023Q4 2022-$0.82-$1.63 -$0.81-$1.63--

Immunic Earnings - Frequently Asked Questions

Immunic has not confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, February 20th, 2025 based off last year's report dates. Learn more on IMUX's earnings history.

In the previous quarter, Immunic (NASDAQ:IMUX) missed the analysts' consensus estimate of ($0.22) by $0.02 with a reported earnings per share (EPS) of ($0.24). Learn more on analysts' earnings estimate vs. IMUX's actual earnings.

The conference call for Immunic's latest earnings report can be listened to online.
Listen to Conference Call

Immunic's earnings report can be found in their filing with the SEC.
View SEC filing

Immunic (NASDAQ:IMUX) has a recorded net income of -$93.61 million. IMUX has generated -$1.23 earnings per share over the last four quarters.

Immunic's earnings are expected to grow from ($0.94) per share to ($0.82) per share in the next year.

More Earnings Resources from MarketBeat



This page (NASDAQ:IMUX) was last updated on 1/21/2025 by MarketBeat.com Staff
From Our Partners